fashion -WSS

fashion

author：leisure time 2025-10-01 04:10:21 - browse：6535

Emma Walmsley on stage at the 2023 STAT Summit. — GSK CEO Emma Walmsley at the 2023 STAT Summit. STAT

The story of GSK is one of reinvention, CEO Emma Walmsley said at the STAT Summit in Boston on Thursday. Having shed its consumer division, the British drug giant is writing a new chapter as a pure-play biopharma company dedicated to the prevention, as well as treatment, of disease.

GSK’s recent launch of a new RSV vaccine for adults is emblematic of this move, adding to a portfolio that includes other vaccines, such as the very successful Shingrix for shingles, as well as drugs for HIV, other infectious diseases, and cancer, among others. But what does the growing sentiment against vaccination, not just in the United States but around the world, mean for such a bet on this market?

“It’s a very, very serious issue,” Walmsley said, noting that in 11 U.S. states, basic vaccination rates are now lower than they were before Covid. “The answer can’t be sort of flinging science over the airwaves and saying ‘trust us,’ because people don’t. There is a really serious challenge of misinformation and the ongoing issue of politicization, which I suspect is going to get more challenging in the next year for obvious reasons.”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Moonlake's readout produced a cash windfall. Risks remain
Next article： UnitedHealth has 90,000 doctors — 10% of all physicians in U.S.

WSS

Pediatric cancer treatments threatened by a new FDA policy

FTC sues over Novant Health acquisition of two N.C. hospitals

The Affordable Care Act has saved billions in health care costs

U.K. Biobank has 500,000 peoples' genome sequences available

How generative AI ratchets up security threats for health systems

White House pharmacy plagued with problems, investigation finds

focus

fashion

focus

Novavax promises a turnaround & Lilly roils the obesity market

The EPA's new lead rule: How one expert crunched the numbers

Hepatitis C has a cure — but many Americans still lack access to it

Despite FDA concern, risk that CAR

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

The latest on Bluebird gene therapies, Vertex's pain drug, and ADC FOMO

Dobbs anniversary: the lost opportunity of abortion as health care

Despite FDA concern, risk that CAR

How to save PrEP access — and even expand it

BIO selects John Crowley as new CEO

entertainment

Is mRNA technology the right fit for flu shots? Experts aren’t so sure

Vertex non

Saudi VC loops Novo Nordisk, biotech VCs into longevity incubator

Medicare Advantage insurers face 0.2% cut to 2025 payments

Philips to halt sales of sleep apnea machines in U.S.

Bernie Sanders is gearing up to subpoena pharma CEOs

Wikipedia

explore

explore

Wikipedia